LAURA PETERSEN to Dose-Response Relationship, Drug
This is a "connection" page, showing publications LAURA PETERSEN has written about Dose-Response Relationship, Drug.
Connection Strength
0.060
-
Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare System. Cardiovasc Drugs Ther. 2021 06; 35(3):533-538.
Score: 0.032
-
Incorporating Guideline Adherence and Practice Implementation Issues into the Design of Decision Support for Beta-Blocker Titration for Heart Failure. Appl Clin Inform. 2018 04; 9(2):478-489.
Score: 0.028